Alnylam Pharmaceuticals, Inc.
ALNY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $966,428 | $812,688 | $866,394 | $819,975 |
| Short-Term Investments | $1,728,076 | $1,626,694 | $1,326,012 | $1,615,589 |
| Receivables | $405,308 | $327,787 | $237,963 | $198,571 |
| Inventory | $78,509 | $89,146 | $128,962 | $86,363 |
| Other Curr. Assets | $116,964 | $126,382 | $132,916 | $0 |
| Total Curr. Assets | $3,295,285 | $2,982,697 | $2,692,247 | $2,808,576 |
| Property Plant & Equip (Net) | $693,932 | $725,789 | $738,630 | $733,633 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $116,863 | $10,101 | $0 | $0 |
| Other NC Assets | $133,903 | $111,293 | $115,482 | $101,095 |
| Total NC Assets | $944,698 | $847,183 | $854,112 | $834,728 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,239,983 | $3,829,880 | $3,546,359 | $3,643,304 |
| Liabilities | – | – | – | – |
| Payables | $88,415 | $55,519 | $98,094 | $73,426 |
| Short-Term Debt | $113,018 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $55,481 | $102,753 | $42,105 | $149,483 |
| Other Curr. Liab. | $214,399 | $177,161 | $170,979 | $130,662 |
| Total Curr. Liab. | $1,186,272 | $967,786 | $767,915 | $695,710 |
| LT Debt | $2,358,974 | $1,020,776 | $1,016,942 | $675,697 |
| Deferred Rev, NC | $0 | $188,175 | $193,791 | $152,360 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $398,108 | $1,630,686 | $1,464,595 | $1,249,987 |
| Total NC Liab. | $2,986,623 | $3,082,738 | $2,936,667 | $2,359,391 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $271,427 | $284,611 | $303,306 | $321,895 |
| Total Liabilities | $4,172,895 | $4,050,524 | $3,704,582 | $3,055,101 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,293 | $1,259 | $1,240 | $1,202 |
| Retained Earnings | -$7,287,748 | -$7,009,591 | -$6,569,349 | -$5,438,193 |
| AOCI | -$34,518 | -$23,375 | -$44,654 | -$33,259 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $67,088 | -$220,644 | -$158,223 | $588,203 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,239,983 | $3,829,880 | $3,546,359 | $3,643,304 |
| Net Debt | $1,505,564 | $208,088 | $150,548 | -$144,278 |